Physician profile
Jeffrey Yao
NPI 1699821942
$622,141.12
in general payments reported to CMS, 2019-2025
30 companies · $25K in 2025
The $25K reported for 2025 was more than what 96% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58K · 2020: $66K · 2021: $130K · 2022: $138K · 2023: $153K · 2024: $52K · 2025: $25K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $114K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $81K · Consulting Fee: $22K · Food and Beverage: $8,612 · Travel and Lodging: $3,538.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $114,371.11 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $81,287.98 |
| Consulting Fee | $22,285.00 |
| Food and Beverage | $8,611.86 |
| Travel and Lodging | $3,537.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $506,695.55 | 2019-2024 | Arthrex |
| Acumed LLC | $73,139.74 | 2019-2025 | Acumed, Innate Implant, Acumed |
| Trice Medical, INC. | $15,528.03 | 2019-2024 | |
| Medical Device Business Services, INC. | $11,575.17 | 2019-2023 | |
| Exsomed Corporation | $5,073.29 | 2019-2022 | |
| Axogen | $2,562.11 | 2019-2025 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector |
| Trimed, INC. | $2,278.00 | 2021-2025 | |
| Stryker Corporation | $1,543.32 | 2024 | Variax |
| Endo Pharmaceuticals INC. | $855.16 | 2023-2024 | Xiaflex |
| Alafair Biosciences, INC. | $385.07 | 2023-2025 | Versawrap |
| Depuy Synthes Sales INC. | $297.34 | 2019-2025 | Vapr, Na |
| Pacira Pharmaceuticals Incorporated | $276.00 | 2022 | |
| Synthes Gmbh | $250.00 | 2022 | |
| Bioventus LLC | $237.16 | 2019-2020 | |
| Evolution Surgical, INC | $226.97 | 2023-2025 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tenex Health INC. | $186.25 | 2020-2021 | |
| Endo USA, INC. | $170.99 | 2025 | Xiaflex |
| Globus Medical, INC. | $167.51 | 2023 | Mini Fragment System |
| Zimmer Biomet Holdings, INC. | $122.84 | 2021 | |
| Native Surgical, LLC | $102.44 | 2025 | |
| Arthrosurface Incorporated | $95.42 | 2019 | |
| Checkpoint Surgical, INC | $93.75 | 2023 | Checkpoint Stimulators |
| Ossio INC | $66.62 | 2023 | |
| Medartis INC. | $55.92 | 2023 | Aptus |
| Kls-Martin L.P. | $39.61 | 2022 | |
| Wright Medical Technology, INC. | $31.54 | 2019 | |
| Osteocentric Technologies, INC. | $31.45 | 2020 | |
| Pinnacle, INC | $19.79 | 2022 | |
| Orthofix Medical, INC. | $19.08 | 2025 | Physio-Stim |
| Integra Lifesciences Corporation | $15.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$351.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Yao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.